<- Go Home
Mallinckrodt PLC
Mallinckrodt PLC develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies. The company offers autoimmune and rare diseases in specialty areas like neurology, rheumatology, nephrology, pulmonology, and ophthalmology; immunotherapy and neonatal respiratory critical care therapies, analgesics and gastrointestinal products. The company was founded in 1867 and is based in Dublin, Ireland.
Market Cap
N/A
Volume
N/A
Cash and Equivalents
$382.6M
EBITDA
$515.5M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$1.1B
Profit Margin
54.45%
52 Week High
N/A
52 Week Low
N/A
Dividend
N/A
Price / Book Value
N/A
Price / Earnings
N/A
Price / Tangible Book Value
N/A
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
$398.3M
Return on Equity
33.97%
Return on Assets
7.08
Cash and Short Term Investments
$382.6M
Debt
$975.2M
Equity
$1.6B
Revenue
$2.0B
Unlevered FCF
$444.9M
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium